travoprost ophthalmic solution 0.004%
travoprost ophthalmic solution 0.004% is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
Divided Dose of TRAVATAN®
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Clinical Trials (9)
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
Divided Dose of TRAVATAN®
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Travoprost 3-Month Safety and Efficacy Study
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9